Malignant tumor metastasis inhibitors
US6869940B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2002 |
| Grant date | Mar 22, 2005 |
| Priority date | — |
| Expiry date | Aug 8, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/593
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inhibiting bone metastasis of a malignant tumor in a patient who has a cancer excluding breast cancer comprises administering to said patient an effective amount of a compound of the formula (III): wherein R2 represents a C1-C10 alkyl group substituted by one or more hydroxyl groups is provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.